# Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin

> **NCT03735134** · NA · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Inflammation
- Myocardial Infarction

## Interventions

- **DRUG:** Colchicine Loading Dose
- **DRUG:** Standard of care treatment prior to elective PCI

## Key facts

- **NCT ID:** NCT03735134
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2018-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03735134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03735134, "Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03735134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*